FDANonrulemakingFDA-2018-D-1456

Who commented on this docket

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-the-Counter Monograph: Study Elements and Considerations; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-the-Counter Monograph: Study Elements and Considerations; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2927d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2927d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.